215 related articles for article (PubMed ID: 32631352)
1. The association of dietary patterns with endocannabinoids levels in overweight and obese women.
Yagin NL; Hajjarzadeh S; Aliasgharzadeh S; Aliasgari F; Mahdavi R
Lipids Health Dis; 2020 Jul; 19(1):161. PubMed ID: 32631352
[TBL] [Abstract][Full Text] [Related]
2. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion.
Little TJ; Cvijanovic N; DiPatrizio NV; Argueta DA; Rayner CK; Feinle-Bisset C; Young RL
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E489-E495. PubMed ID: 29438631
[TBL] [Abstract][Full Text] [Related]
3. Comparison of endocannabinoids levels, FAAH gene polymorphisms, and appetite regulatory substances in women with and without binge eating disorder: a cross- sectional study.
Yagin NL; Aliasgari F; Alizadeh M; Aliasgharzadeh S; Mahdavi R
Nutr Res; 2020 Nov; 83():86-93. PubMed ID: 33038759
[TBL] [Abstract][Full Text] [Related]
4. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D
Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878
[TBL] [Abstract][Full Text] [Related]
6. Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat.
Castonguay-Paradis S; Lacroix S; Rochefort G; Parent L; Perron J; Martin C; Lamarche B; Raymond F; Flamand N; Di Marzo V; Veilleux A
Sci Rep; 2020 Sep; 10(1):15975. PubMed ID: 32994521
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease.
Zelber-Sagi S; Azar S; Nemirovski A; Webb M; Halpern Z; Shibolet O; Tam J
Obesity (Silver Spring); 2017 Jan; 25(1):94-101. PubMed ID: 27863097
[TBL] [Abstract][Full Text] [Related]
8. Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.
Nicholson J; Azim S; Rebecchi MJ; Galbavy W; Feng T; Reinsel R; Rizwan S; Fowler CJ; Benveniste H; Kaczocha M
PLoS One; 2015; 10(4):e0123132. PubMed ID: 25835291
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes.
Thompson Z; Argueta D; Garland T; DiPatrizio N
Physiol Behav; 2017 Mar; 170():141-150. PubMed ID: 28017680
[TBL] [Abstract][Full Text] [Related]
10. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
[TBL] [Abstract][Full Text] [Related]
11. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
[TBL] [Abstract][Full Text] [Related]
12. The association of circulating endocannabinoids with appetite regulatory substances in obese women.
Lotfi Yagin N; Aliasgharzadeh S; Alizadeh M; Aliasgari F; Mahdavi R
Obes Res Clin Pract; 2020; 14(4):321-325. PubMed ID: 32580926
[TBL] [Abstract][Full Text] [Related]
13. Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.
van Eyk HJ; van Schinkel LD; Kantae V; Dronkers CEA; Westenberg JJM; de Roos A; Lamb HJ; Jukema JW; Harms AC; Hankemeier T; van der Stelt M; Jazet IM; Rensen PCN; Smit JWA
Nutr Diabetes; 2018 Jan; 8(1):6. PubMed ID: 29343706
[TBL] [Abstract][Full Text] [Related]
14. Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial.
Pei R; DiMarco DM; Putt KK; Martin DA; Gu Q; Chitchumroonchokchai C; White HM; Scarlett CO; Bruno RS; Bolling BW
Br J Nutr; 2017 Dec; 118(12):1043-1051. PubMed ID: 29179781
[TBL] [Abstract][Full Text] [Related]
15. Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea.
Wang X; Yu Q; Yue H; Zhang J; Zeng S; Cui F
Biomed Res Int; 2016; 2016():9782031. PubMed ID: 26904688
[TBL] [Abstract][Full Text] [Related]
16. A Role for Peripheral Anandamide and 2-Arachidonoylglycerol in Short-Term Food Intake and Orexigenic Hypothalamic Responses in a Species with Continuous Nutrient Delivery.
van Ackern I; Kuhla A; Kuhla B
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684588
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids concentrations in plasma associated with feed efficiency and carcass composition of beef steers.
Artegoitia VM; Foote AP; Lewis RM; King DA; Shackelford SD; Wheeler TL; Freetly HC
J Anim Sci; 2016 Dec; 94(12):5177-5181. PubMed ID: 28046144
[TBL] [Abstract][Full Text] [Related]
18. Circulating Endocannabinoids and Mortality in Hemodialysis Patients.
Moradi H; Park C; Streja E; Argueta DA; DiPatrizio NV; You AS; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D
Am J Nephrol; 2020; 51(2):86-95. PubMed ID: 31935741
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity.
Brocato B; Zoerner AA; Janjetovic Z; Skobowiat C; Gupta S; Moore BM; Slominski A; Zhang J; Schenone M; Phinehas R; Ferry RJ; Dick E; Hubbard GB; Mari G; Schlabritz-Loutsevitch N
Placenta; 2013 Nov; 34(11):983-9. PubMed ID: 24008071
[TBL] [Abstract][Full Text] [Related]
20. Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet.
Haidari F; Aghamohammadi V; Mohammadshahi M; Ahmadi-Angali K; Asghari-Jafarabadi M
Trials; 2020 Jul; 21(1):657. PubMed ID: 32680548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
